NF-?B in cancer therapy
MetadataShow full item record
© 2015, Springer-Verlag Berlin Heidelberg. The transcription factor nuclear factor kappa B (NF-?B) has attracted increasing attention in the field of cancer research from last few decades. Aberrant activation of this transcription factor is frequently encountered in a variety of solid tumors and hematological malignancies. NF-?B family members and their regulated genes have been linked to malignant transformation, tumor cell proliferation, survival, angiogenesis, invasion/metastasis, and therapeutic resistance. In this review, we highlight the diverse molecular mechanism(s) by which the NF-?B pathway is constitutively activated in different types of human cancers, and the potential role of various oncogenic genes regulated by this transcription factor in cancer development and progression. Additionally, various pharmacological approaches employed to target the deregulated NF-?B signaling pathway, and their possible therapeutic potential in cancer therapy is also discussed briefly.
Showing items related by title, author, creator and subject.
Towards understanding disparities in cancer outcomes for Aboriginal Australians: exploring Aboriginal perceptions and experiences of cancer in Western AustraliaShahid, Shaouli (2010)Cancer has become one of the major chronic diseases among Aboriginal and Torres Strait Islander people of Australia, and was declared a health priority in the National Aboriginal and Torres Strait Islander Health Strategy ...
Rates of colonoscopy in the 3 years prior to a diagnosis of colorectal cancer in Western Australia: assessment of risk factors for missed and interval cancers. Preliminary results from a population-based studySalama, M.; Harma, C.; Fritschi, Lin; Heyworth, J.; Raftopoulos, S.; Ee, H. (2014)Introduction and Aims: Colonoscopy is the gold standard for diagnosing colorectal cancer (CRC) however there is a miss rate for cancers of up to 7.9%, with significant variability in this figure from different populations ...
Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomesChua, A.; Knuiman, M.; Trinder, D.; Divitini, M.; Olynyk, John (2016)© 2016 American Society for Nutrition.Background: Although the carcinogenic potential of iron has been shown, evidence from observational studies that have linked serum iron variables and cancer outcomes has been inconsistent. ...